Articles |
From the Department of Physiology and Medicine, University of Antwerp (Belgium).
Correspondence to Dirk L. Brutsaert, MD, PhD, Department of Physiology and Medicine, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
| Abstract |
|---|
|
|
|---|
Key Words: free radicals endocardial endothelium endothelial dysfunction endothelin cardiac muscle
| Introduction |
|---|
|
|
|---|
Endothelial dysfunction has been defined as an imbalance between endothelium-derived vascular relaxing and contracting factors, between anticoagulant and procoagulant mediators, and between growth-inhibiting and growth-promoting factors and is thought to participate in the initiation and/or progression of numerous cardiovascular diseases, including hypertension, hyperlipidemia, atherosclerosis, microvascular angina, diabetic angiopathies, reperfusion injury, and heart failure (for review see Reference 1111 ). To what extent (endo)cardial endothelial dysfunction results in a disturbed control of cardiac performance, cell growth, or other cardiac functions by an imbalanced release of endothelin-1, NO, prostaglandins, or other factors has not yet been established.
Reactive oxygen species (ROS) are continuously formed in vivo. ROS participate in the pathogenesis of various diseases, such as hypertension,12 atherosclerosis,13 diabetes mellitus,14 ischemia/reperfusion injury,15 and heart failure,16 probably by modulating or impairing endothelial cell function. In addition, ROS have also been ascribed a role in physiological endothelium-mediated regulation of vascular tone.17 Since endothelial cells can be both a target and a source for ROS,18 19 interaction between ROS and the endothelium thus appears to play an important role in normal and abnormal cardiovascular homeostasis.
In the present study, we investigated the influence of ROS on the action of endocardial endothelium (EE) on myocardial performance. Therefore, the contractile response of isolated papillary muscles to electrolysis-generated ROS was examined in the presence or absence of EE and/or inhibitors of endothelium-derived cardioactive substances. We preferred electrolysis above pharmacological or enzymatic ROS-producing procedures mainly because it offered the possibility of an on/off oxidative stress, short enough to avoid myocardial damage. Possible endothelial and myocardial cell damage was assessed biochemically by measurement of lipid peroxidation products and morphologically by confocal scanning laser microscopic observations of muscles stained with viability tracers.
| Materials and Methods |
|---|
|
|
|---|
10% above threshold by rectangular
pulses of 5-ms duration through two longitudinally arranged platinum
electrodes.
Electrolysis-Induced Oxidative Stress
ROS were produced by electrolyzing the bathing solution through
two additional platinum electrodes (1x2 cm), flanking the contracting
muscle perpendicularly to the two stimulation electrodes. A constant
current (DC) generated by an RP 216 current unit (Eagle Products) was
applied through these electrodes into the bathing solution. Generation
of ROS by electrolyzing a physiological buffer solution has been
described by Jackson et al20 and has been used frequently
to investigate the influence of ROS in the cardiovascular system. In
the present study, electrolysis was continued for only 15 s by use
of a current intensity of 30 mA, which was far below the level (ie, 60
mA or more) at which fibrillatory movements of the muscle were evoked
during electrolysis.
In a few experiments without isolated muscles in the bath, ROS production in the Krebs-Ringer solution was assayed by fluorescence measurements of dihydrorhodamine 123. During electrolysis, aliquots of 1 mL were taken from the Krebs-Ringer solution between the electrodes, immediately (sampling time, <1 s) placed in cuvettes containing 1 mL of dihydrorhodamine 123 (final concentration, 1 µmol/L), and shaken. Fluorescence was determined with a Shimadzu RF-500 spectrofluorometer at 530-nm emission wavelength, the intensity of the fluorescence being recorded as a millivolt response. Fluorescence was quantified by the xanthine oxidase/xanthine reaction, in which the generation of ROS was measured by the reduction of cytochrome C.
Experimental Protocol
After a stabilization period of at least 2 hours at 29°C, the
temperature was increased to 35°C, the temperature at which the
actual experiments were performed. Further stabilization of the muscles
was continued for
1 hour at the muscle length at which the maximal
active tension was developed (lmax) until steady state was obtained.
After electrolysis, contractile performance, derived from isotonic and
isometric twitches, was followed for 1 hour. Contribution of ROS to the
electrolysis-induced effects on myocardial performance was verified by
performing experiments with muscles incubated (30 minutes before
electrolysis) with ROS scavengers, including superoxide dismutase (SOD,
100 U/mL), catalase (CAT, 120 U/mL), and ascorbic acid (1 µmol/L),
all obtained from Sigma Chemical Co. After 15 s of electrolysis
(current intensity, 30 mA), contractile performance was followed for at
least 1 hour.
The role of the EE and EE-derived factors in the ROS-induced response was studied by performing parallel experiments in four groups of muscles. In the first group, the control group, EE was undamaged, and no inhibitors or antagonists were added. In the second group, EE was selectively damaged 30 minutes before electrolysis by a 1-s immersion of muscles in 0.5% Triton X-100 (Sigma) while in their working position, immediately followed by an abundant wash (>250 mL) with control Krebs-Ringer solution at 35°C. As previously described, this procedure resulted in a characteristic alteration of the isometric twitch6 : early onset of relaxation with concomitant decrease in peak twitch but with no significant changes in the maximal calcium-activated force. Selective damage of the EE and functional as well as morphological integrity of the subjacent myocardium after this procedure have also been extensively discussed previously.6 In the third and fourth groups, muscles were incubated 30 minutes before electrolysis with NG-nitro-L-arginine methyl ester (L-NAME, 1 mmol/L, Sigma; an NO synthase blocker) plus indomethacin (1 µmol/L, Sigma; a cyclooxygenase inhibitor) (third group) or with BQ 123 (1 or 3 µmol/L, Sigma; a competitive endothelin-A receptor antagonist) (fourth group). Neither L-NAME+indomethacin nor BQ 123 consistently influenced basal contractile parameters. In addition, in intact muscles cumulative concentration responses were obtained for exogenous endothelin-1 (from 0.1 nmol/L to 0.1 µmol/L, Sigma) in the absence (n=3) and presence (n=3) of BQ 123 (1 µmol/L, added 30 minutes before endothelin-1 administration).
Measurements of Lipid Peroxidation
Lipid peroxidation was determined by using the thiobarbituric
acid reaction. This reaction reveals several oxidized substances
(thiobarbituric acid reaction substances [TBARS]).
At 5, 10, 15, and 30 minutes after electrolysis (30 mA, 15 s), 1 mL of a 30 mL Krebs-Ringer solution containing the muscle preparation was mixed with 2 mL of 0.375% thiobarbituric acid and 15% trichloroacetic acid in 0.25N HCl. The mixture was left at room temperature for 10 minutes, then heated to 80°C for 15 minutes, cooled to room temperature, and centrifuged at 1000g for 15 minutes. The supernatant was used to measure TBARS absorbance at 532 nm.
Confocal Scanning Laser Microscopy and Viability Tracers
Cellular viability of myocardial and endothelial cells was
assayed by using ethidium homodimer, TOPRO, and Bodipy phallacidin (all
from Molecular Probes). Both ethidium homodimer and TOPRO are, like
propidium iodide and other viability tracers, impermeant to live cells
but bind to DNA and RNA in cells with a damaged
membrane.21 22 Ethidium homodimer (final concentration,
0.7 µmol/L) was added to the bathing solution after the experiment,
before fixation, thus only staining DNA and RNA of cells damaged during
the experiment. For quantification of cellular damage, TOPRO staining
was performed after fixation, thus staining the nuclei of all cells. In
addition, all papillary muscles were stained en block with Bodipy
phallacidin (3.3 µmol/L). Bodipy phallacidin binds specifically to
filamentous actin (F-actin).23 Strips of stained specimens
were mounted, endothelial surface at the top, in a small chamber on a
slide. For en face observation, a Polyvar 2 epifluorescence microscope
(Reichert) or a model 600 confocal scanning laser microscope (Bio-Rad)
was used.
Data Analysis
Data are expressed as mean±SEM. In the different muscle groups,
the average of the parameter values measured at 20, 30, 40, and 50
minutes after electrolysis was compared with control values (paired
Student's t test). To compare the effect of electrolysis
between the different conditions, a nonparametric Kruskal-Wallis test
was performed on the percent changes induced by electrolysis, followed
by a Dunn-type multiple comparison.
| Results |
|---|
|
|
|---|
|
Influence of Electrolysis-Generated ROS on Contractile
Performance
Electrolyzing the Krebs-Ringer solution surrounding the muscle for
15 s at 30 mA significantly increased peak twitch total tension by
7.8±0.7% (from 49.5±7.7 to 53.2±8.2 mN/mm2,
P<.05) and peak rate of tension development by 9.7±1.5%
(from 270±40 to 288±38 mN/mm2 per second,
P<.05), whereas peak rate of preloaded isotonic shortening
increased by 5.3±1.2% (from 1.03±0.08 to 1.08±0.08 lmax/s,
P<.05) (Fig 2
). Interestingly, isometric
twitch duration (time from stimulus to half relaxation) increased by
2.7±0.6% (from 442±22 to 454±22 ms, P<.05), whereas
time from stimulus to peak twitch total tension did not change. The
onset of the positive inotropic response was slow (5 to 10 minutes
after electrolysis) and remained present until
50 minutes
thereafter (Fig 2
). Replacing the electrolyzed bathing solution by
control Krebs-Ringer solution (same pH and temperature) within 30 s
after interrupting the electrolysis or after the full appearance of the
positive inotropic effect did not influence the above positive
inotropic response. These observations almost certainly exclude the
possibility that the inotropic response resulted from
electrolysis-induced change in pH or other ionic concentrations in the
bathing solution. Of note, during the 15-s electrolysis and thereafter,
resting properties of the muscle were not affected. In a few muscles
(n=4), the mechanical response became highly unstable after
electrolysis; because no steady state was attained, these muscles were
excluded. Electrolysis-induced mechanical instability was observed only
in muscles with an undamaged EE (ie, not Triton treated). Changing the
Krebs-Ringer solution did not interrupt this unstable response.
|
To verify whether ROS were responsible for the contractile changes
induced by electrolysis, similar experiments were performed in the
presence of ROS scavengers, added at least 15 minutes before
electrolysis. A combination of SOD (100 U/mL) and CAT (120 U/mL) was
added in eight muscle preparations with an undamaged EE. Ascorbic acid
(1 µmol/L) was added in another six preparations with an undamaged
EE. In the presence of these scavengers, no inotropic response could be
observed after electrolysis (Fig 3
). Similarly, CAT
alone (n=6, 120 U/mL) completely suppressed the inotropic response. By
contrast, SOD alone (n=6, 100 U/mL) did not significantly influence the
basic observations (Fig 3
).
|
Atenolol (1 µmol/L), a hydrophilic ß-adrenergicblocking agent, added to the bathing solution 15 minutes before electrolysis did not affect the inotropic response of muscles to electrolysis (data not shown, n=6). A comparable increase in isometric and isotonic inotropic parameters as well as in isometric twitch duration was observed in the presence or absence of atenolol. This observation excluded the possibility that the inotropic response resulted from the release of endogenous catecholamines during electrolysis.
Role of EE and Endothelium-Derived Substances
Electrolysis did not influence contractile performance of isolated
cardiac muscle when the EE had been selectively damaged 30 minutes
before electrolysis (Fig 4
), suggesting that inotropic
agents released from the EE were responsible for the positive inotropic
effect after electrolysis in muscles with an undamaged EE. Therefore,
experiments were repeated with muscles incubated with synthesis
inhibitors or antagonists of known EE-derived metabolic substances
added to the bathing solution 30 minutes before electrolysis.
Preincubation with L-NAME (1 mmol/L) and indomethacin (1
µmol/L) (n=5) did not alter the inotropic response induced by
electrolysis (Fig 4
), suggesting that neither EE-derived NO nor
EE-derived cyclooxygenase products were involved. Preincubation with BQ
123, a competitive endothelin-A receptor antagonist, reduced the
positive inotropic response at 1 µmol/L (n=6, Fig 4
) and completely
suppressed the response at 3 µmol/L (peak twitch total tension,
97.1±1.6% of baseline; maximal rate of tension development,
97.3±0.8% of baseline; n=5).
|
In intact cardiac muscles (n=6), concentration-response experiments with exogenous endothelin-1 in the absence and presence of BQ 123 (1 µmol/L) revealed that the pattern of endothelin-1induced positive inotropic effect was similar to the ROS-induced effect. In particular, at a concentration of 0.1 nmol/L, peak twitch total tension increased by 10.0±1.5%, peak rate of tension development increased by 13.9±2.0%, and time from stimulus to half relaxation increased by 2.7±0.2%, whereas time from stimulus to peak isometric tension did not change, suggesting that a similarly effective concentration of endothelin-1 was released by the EE after ROS production. In addition, similar to the ROS-induced effect, the positive inotropic effect appeared only 5 to 7 minutes after endothelin-1 administration, was neither transient nor washable, and was blocked by preincubating the muscles with 1 µmol/L BQ 123 (peak twitch total tension, 101.9±1.1% of baseline; maximal rate of tension development, 103.0±1.8% of baseline).
Effect of Electrolysis-Generated ROS on Cellular Viability
Measurements of Lipid Peroxidation Products
Detection of lipid peroxidation by the thiobarbituric acid
reaction at 5, 10, 15, and 30 minutes after electrolysis did not reveal
any elevation in the amount of TBARS in the Krebs-Ringer solution (data
not shown). This result suggested that the brief electrolysis-induced
oxidative stress did not induce major membrane damage or cell
death.
Functional Morphology of EE and Myocardium
En face optical sections through the EE of electrolysis-treated
muscles and dual-channel observations with the confocal scanning laser
microscope revealed two different states of EE cells.
EE cells with nuclei intensively labeled by ethidium
homodimer. These cells (Fig 5C
)
represented nonviable cells, as further suggested by the
absence of actin staining and by the absence of cytoplasmic ethidium
homodimer staining surrounding the nuclei, which indicated that F-actin
was disassembled and that RNA had been washed out.
|
EE cells without labeling of the nuclei by ethidium homodimer and
with a normal F-actin pattern. These cells (Fig 5A
and 5C
)
represented viable cells with an intact cell membrane. As
in the EE of rat hearts,24 actin filaments usually
outlined the periphery of cat EE cells and, less frequently, formed
centrally located stress fibers. In some cells with a normal F-actin
pattern, the nuclei were weakly stained with ethidium homodimer,
indicating that some membrane damage had occurred (Fig 5B
). The
cytoplasmic staining surrounding the nuclei showed, however, that RNA
had not been washed out (Fig 5B
). These cells were probably still
viable but might have been dysfunctional.
The proportion of viable to nonviable EE cells in five
electrolysis-treated muscles was quantified and compared with four
control muscles. Therefore, the number of nonviable EE cells (ie, the
number of EE nuclei intensively stained with ethidium homodimer) was
compared with the total number of EE cells (ie, the number of EE nuclei
stained with TOPRO). In both muscle groups, some "naked" zones
without EE cells were observed. The actual total number of EE cells per
104-µm2 muscle surface was not significantly
different in control muscles (19.9±1.2) and in electrolysis-treated
muscles (15.5±3.0) (Mann-Whitney, P>.05). Of these latter
cells, 42±5% were intensively stained with ethidium homodimer and
thus nonviable (versus 14±4% in control muscles; Mann-Whitney,
P<.05). Optical sections and dual-channel observations of
subendothelial myocardium demonstrated the presence of intact myocytes
with a normal striation pattern of F-actin (Fig 5D
).
In conclusion, although electrolysis was probably too brief to completely damage the EE or to damage any of the underlying myocytes, significantly more EE cells were damaged in electrolysis-treated muscles than in control muscles.
| Discussion |
|---|
|
|
|---|
Cardiac endothelium (more specifically, EE) releases at least three
chemical messengers that may influence myocardial performance. First,
EE cells express NO synthase (constitutive2 and
inducible27 form). NO release by EE cells has been shown
to elevate myocardial cGMP.10 The influence of EE-derived
NO and the NO-cGMP pathway in the modulation of myocardial performance
has been the subject of recent experiments in our and other
laboratories. Shah and colleagues28 29 have reported that
NO and cGMP decreased myocardial contraction in isolated ferret
papillary muscles28 and in isolated
cardiomyocytes,29 whereas Mohan et al30 have
recently shown that the inotropic effect of cGMP in isolated cat
papillary muscles is concentration dependent and relies on the state of
the EE. Second, Mebazaa and colleagues3 31 demonstrated
that cultured EE from sheep in basal conditions released large amounts
of prostaglandins, up to 20 times more than vascular
endothelium,3 and that this release increased further
during hypoxia.31 However, the role of prostaglandins in
the control of myocardial performance is not well understood. Because
the presently described EE-dependent positive inotropic response
was not altered by a combination of an NO synthase inhibitor (L-NAME)
and a cyclooxygenase inhibitor (indomethacin) (Fig 4
), the response
could not be accounted for by EE-derived NO and prostaglandins. Third,
EE cells contain endothelin-1 mRNA.1 In the heart,
endothelin-1 is highly inotropic1 and
vasoconstrictive,32 even at low concentrations, and
enhances cardiac cell growth.33 Recently, McClellan et
al34 proposed endothelin storage and release from coronary
endothelial cells as a cardioregulatory mechanism. Although the
present data may add further evidence for endothelin release in
vascular endothelium and EE as a cardioregulatory mechanism, a
definitive conclusion about a role for endothelin in physiological
regulation of cardiac function requires further investigation. The
pathophysiological importance of endothelin in the cardiovascular
system is suggested by the elevated plasma concentration of endothelin
in various disorders, such as hypertension, atherosclerosis, myocardial
infarction, and heart failure.35
The present study suggests that ROS may be a trigger for endothelin release from EE cells. To most investigators, ROS are believed to have biological importance only by their toxic effects, eg, by damaging or killing cells in pathophysiological conditions. However, growing experimental evidence suggests that nontoxic properties of ROS may be involved in normal aerobic biology. ROS have been involved in the physiological regulation of in vivo vascular tone by interaction with the endothelium.17 A chronic imbalance between ROS and oxidant defense, however, impairs endothelial function and may be involved in the initiation or progression of various cardiovascular diseases, including hypertension,12 atherosclerosis,13 diabetes,14 and myocardial stunning.15 In our experiments, confocal scanning laser microscopy of muscles only briefly exposed to electrolysis-generated ROS revealed that the myocytes were viable and had a normal actin pattern but that significantly more, but not all, EE cells were damaged when compared with control preparations. The functional state of partly damaged EE after electrolysis seems to resemble dysfunctional vascular endothelium, where an imbalanced release of endothelin compared with vasorelaxant substances (particularly NO) is characteristic.11 Hence, the present endothelin-mediated positive inotropic effect of electrolysis-generated ROS describes, for the first time, in vitro implications of EE dysfunction on myocardial contractility. ROS-induced enhanced endothelin release from dysfunctional EE cells in vivo may influence cardiac performance, coronary tone, and cardiac cell growth and thus be involved in the progression of cardiac diseases.
Conclusion
In conclusion, the present study demonstrates that a brief
burst of electrolysis-generated ROS, which partly damaged the
endocardial surface, increased contraction of isolated cat papillary
muscle by stimulating endothelin release from EE cells. Hence,
ROS-induced endothelin release from EE may participate in normal and/or
pathological myocardial physiology.
Limitations of the Study
The present results describe in vitro observations of isolated
papillary muscles in highly oxygenated aqueous buffer. The function of
both EE and myocardium may differ significantly from in vivo
conditions. In addition, the present results could be specific to
electrolysis-induced oxidative stress. Therefore, extrapolating the
present results to oxidative stress in general, and especially to
oxidative stress in vivo, where many endogenous antioxidant mechanisms
are operative, must be done cautiously. However, electrolysis of a
physiological buffer solution has been demonstrated to be a reliable
method to produce various ROS, such as superoxide anion radical,
hydrogen peroxide, hydroxyl radical, and hypochlorite. We preferred
electrolysis rather than pharmacological or enzymatic ROS-producing
procedures mainly because it offered the possibility of an on/off
oxidative stress that was short enough to avoid myocardial damage.
Moreover, because of the gradual appearance of the inotropic response,
which was not affected by replacing the bathing solution, it seemed
unlikely that electrolysis-induced changes (other than ROS production),
such as transient changes in pH or ionic concentrations, participated
in the response.
| Acknowledgments |
|---|
Received March 2, 1994; accepted January 19, 1995.
| References |
|---|
|
|
|---|
2. Schulz R, Smith JA, Lewis MJ, Moncada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol. 1991;104:21-24. [Medline] [Order article via Infotrieve]
3. Mebazaa A, Martin LD, Robotham JL, Maeda K, Gabrielson EW, Wetzel RC. Right and left ventricular cultured endocardial endothelium produces prostacyclin and PGE2. J Moll Cell Cardiol. 1993;25:245-248. [Medline] [Order article via Infotrieve]
4.
Brutsaert DL, Andries LA. The endocardial endothelium.
Am J Physiol. 1992;263:H985-H1021.
5.
Ramaciotti C, McClellan G, Sharkey A, Rose D, Weisberg A,
Winegrad S. Cardiac endothelial cells modulate contractility of rat
hearts in response to oxygen tension and coronary flow.
Circ Res. 1993;72:1044-1064.
6. Brutsaert DL, Meulemans AL, Sipido KR, Sys SU. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res. 1988;62:357-366.
7.
Li K, Rouleau JL, Andries LJ, Brutsaert DL. Effect of
dysfunctional vascular endothelium on myocardial performance in
isolated papillary muscles. Circ Res. 1993;72:768-777.
8. Fort S, Lewis MJ, Shah AM. The role of endocardial endothelium in the modulation of myocardial contraction in the isolated whole heart. Cardioscience. 1993;4:217-223. [Medline] [Order article via Infotrieve]
9. Gillebert TC, De Hert SG, Andries LJ, Jageneau AH, Brutsaert DL. Intracavitary ultrasound impairs left ventricular performance: presumed role of endocardial endothelium. Am J Physiol. 1992;263:H857-H865. [Abstract]
10.
Smith JA, Shah AM, Lewis MJ. Factors released from endocardium
of the ferret and pig modulate myocardial contraction. J Physiol
(Lond). 1991;439:1-14.
11. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and disease. J Cardiovasc Pharmacol. 1993;22(suppl 4):S1-S14.
12.
Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M.
Does superoxide underlie the pathogenesis of hypertension? Proc
Natl Acad Sci U S A. 1991;88:10045-10048.
13. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344:793-795. [Medline] [Order article via Infotrieve]
14.
Tesfamariam B, Cohen RA. Free radicals mediate endothelial
cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263:H321-H326.
15. Lefer AM, Lefer DJ. Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicals. Basic Res Cardiol. 1991;86(suppl 2):109-116.
16.
Beck JJF, Bridge AB, Scott N, Chopra M. Oxygen free radicals
and congestive heart failure. Br Heart J. 1991;65:245-248.
17.
Laurindo FRM, Pedro M de A, Barbeiro HV, Pileggi F, Carvalho
MHC, Augusto O, da Luz PL. Vascular free radical release: ex vivo and
in vivo evidence for a flow-dependent endothelial mechanism.
Circ Res. 1994;74:700-709.
18.
Zweier JL, Kuppusamy P, Lutty GA. Measurements of endothelial
cell free radical generation: evidence for a central mechanism of free
radical injury in postischemic tissues. Proc Natl Acad Sci
U S A. 1988;85:4046-4050.
19. Arroyo CM, Carmichael AJ, Bouscarel B, Liang JH, Weglicki WB. Endothelial cells as source of oxygen free radicals: an ESR study. Free Radic Res Commun. 1990;9:287-296. [Medline] [Order article via Infotrieve]
20. Jackson CV, Michelson JK, Stringler K, Lucchesi BR. Electrolysis-induced myocardial dysfunction: a novel method for the study of free radical mediated tissue injury. J Pharmacol Methods. 1986;13:305-320.
21. Poole CA, Brookes NH, Clover GM. Keratocyte network visualised in the living cornea using vital dyes. J Cell Sci. 1993;106:685-691. [Abstract]
22. Tymianski M, Charlton MP, Carlen PL, Tator CH. Secondary Ca2+ overload indicates early neuronal injury which precedes staining with viability indicators. Brain Res. 1993;607:319-329. [Medline] [Order article via Infotrieve]
23.
Wulf E, Dedoben A, Bautz FA, Wieland T. Fluorescent
phallotoxin, a tool for the visualization of cellular actin. Proc
Natl Acad Sci U S A. 1979;76:4498-4502.
24. Andries LJ, Brutsaert DL. Endocardial endothelium in the rat: cell shape and organization of the cytoskeleton. Cell Tissue Res. 1993;273:107-117. [Medline] [Order article via Infotrieve]
25.
Ager A, Gordon JL. Differential effects of hydrogen peroxide
on indices of endothelial cell function. J Exp Med. 1984;159:592-603.
26.
Lu D, Moulik N, Moraru I, Kreutzer DL, Das DK. Molecular
adaptation of vascular endothelial cells to oxidative stress. Am
J Physiol. 1993;264:C715-C722.
27. Smith JA, Radomski MW, Schulz R, Moncada S, Lewis MJ. Porcine ventricular endothelial cells in culture express the inducible form of NO-synthase. Br J Pharmacol. 1993;108:1107-1110. [Medline] [Order article via Infotrieve]
28. Shah AM, Lewis MJ, Henderson AH. Effect of 8-bromo cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J Moll Cell Cardiol. 1991;23:55-64. [Medline] [Order article via Infotrieve]
29.
Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG.
8-Bromo-cGMP reduces the myofilament response to
Ca2+ in intact cardiac myocytes.
Circ Res. 1994;74:970-978.
30.
Mohan P, Sys SU, Brutsaert DL. Nitric oxide donors induce a
positive inotropic effect mediated by cGMP in isolated cardiac muscle
without endothelium. Eur Heart J. 1994;15:114. Abstract.
31. Mebazaa A, Cherian M, Abraham M, Dodd-o J, Martin L, Wetzel R. Endocardial endothelial prostanoid release responds to flow and hypoxia with response greater than that of the vascular endothelium. Circulation. 1993;88(suppl I):185. Abstract.
32. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictive peptide produced by vascular endothelial cells. Nature. 1988;332:411-415. [Medline] [Order article via Infotrieve]
33.
Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T,
Nitta M, Taniguchi K, Maruma F. Endothelin-1 induces hypertrophy with
enhanced expression of muscle-specific genes in cultured neonatal rat
cardiomyocytes. Circ Res. 1991;69:209-215.
34.
McClellan G, Weisberg A, Rose D, Winegrad S. Endothelial cell
storage and release of endothelin as a cardioregulatory mechanism.
Circ Res. 1994;75:85-96.
35. Clavell A, Stingo A, Margulies K, Lerman A, Underwood D, Burnett J. Physiological significance of endothelin: its role in congestive heart failure. Circulation. 1993;87(suppl V):V-45-V-50.
This article has been cited by other articles:
![]() |
P. Castro-Chaves, R. Fontes-Carvalho, M. Pintalhao, P. Pimentel-Nunes, and A. F. Leite-Moreira Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart Exp Physiol, June 1, 2009; 94(6): 665 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fransen, R. R Lamberts, J. Hendrickx, and G. W De Keulenaer Endocardial endothelium modulates subendocardial pHi of rabbit papillary muscles: role of transendothelial HCO3- transport Cardiovasc Res, September 1, 2004; 63(4): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mebazaa, G. W. De Keulenaer, X. Paqueron, L. J. Andries, P. Ratajczak, S. Lanone, C. Frelin, D. Longrois, D. Payen, D. L. Brutsaert, et al. Activation of Cardiac Endothelium as a Compensatory Component in Endotoxin-Induced Cardiomyopathy: Role of Endothelin, Prostaglandins, and Nitric Oxide Circulation, December 18, 2001; 104(25): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. TAVERNIER, A. MEBAZAA, P. MATEO, S. SYS, R. VENTURA-CLAPIER, and V. VEKSLER Phosphorylation-dependent Alteration in Myofilament Ca2+ Sensitivity but Normal Mitochondrial Function in Septic Heart Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 362 - 367. [Abstract] [Full Text] |
||||
![]() |
V. J. Thannickal and B. L. Fanburg Reactive oxygen species in cell signaling Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. De Keulenaer, M. Ushio-Fukai, Q. Yin, A. B. Chung, P. R. Lyons, N. Ishizaka, K. Rengarajan, W. R. Taylor, R. W. Alexander, and K. K. Griendling Convergence of Redox-Sensitive and Mitogen-Activated Protein Kinase Signaling Pathways in Tumor Necrosis Factor-{alpha}-Mediated Monocyte Chemoattractant Protein-1 Induction in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-E. Massart, J. Donckier, J. Kyselovic, T. Godfraind, G. R. Heyndrickx, and M. Wibo Carvedilol and Lacidipine Prevent Cardiac Hypertrophy and Endothelin-1 Gene Overexpression After Aortic Banding Hypertension, December 1, 1999; 34(6): 1197 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U Sys, G. W De Keulenaer, and D. L Brutsaert Physiopharmacological evaluation of myocardial performance: how to study modulation by cardiac endothelium and related humoral factors? Cardiovasc Res, July 1, 1998; 39(1): 136 - 147. [Full Text] [PDF] |
||||
![]() |
I. Lahaie, P. Hardy, X. Hou, H. Hassessian, P. Asselin, P. Lachapelle, G. Almazan, D. R. Varma, J. D. Morrow, L. J. Roberts II, et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2alpha on retinal vessels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1406 - R1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Colucci Myocardial Endothelin : Does It Play a Role in Myocardial Failure? Circulation, March 15, 1996; 93(6): 1069 - 1072. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |